Profile
Mark J.
Suseck is currently Chief Operating Officer at Impact BioMedical, Inc. since 2023.
Formerly, served as Chief Executive Officer & Director at Vivacitas Oncology, Inc. from 2021 to 2022.
Worked as Vice President-Marketing at Paradigm Spine LLC.
Held the position of Vice President-Global Sales & Marketing at Solana Co. from 2018 to 2019.
Completed undergraduate education at Rutgers State University of New Jersey.
Mark Suseck active positions
| Companies | Position | Start |
|---|---|---|
| IMPACT BIOMEDICAL INC. | Chief Operating Officer | 01/08/2023 |
Former positions of Mark Suseck
| Companies | Position | End |
|---|---|---|
Vivacitas Oncology, Inc.
Vivacitas Oncology, Inc. Medical/Nursing ServicesHealth Services Provides chemotherapies | Chief Executive Officer | 01/01/2022 |
| SOLANA COMPANY | Sales & Marketing | 01/01/2019 |
Paradigm Spine LLC
Paradigm Spine LLC Medical SpecialtiesHealth Technology Designs, develops and markets solutions for the treatment of spinal conditions and diseases | Sales & Marketing | - |
Training of Mark Suseck
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
Paradigm Spine LLC
Paradigm Spine LLC Medical SpecialtiesHealth Technology Designs, develops and markets solutions for the treatment of spinal conditions and diseases | Health Technology |
Solana Co.
Solana Co. Medical SpecialtiesHealth Technology Operates as a medical technology company focused on neurological wellness | Health Technology |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivacitas Oncology, Inc.
Vivacitas Oncology, Inc. Medical/Nursing ServicesHealth Services Provides chemotherapies | Health Services |
Impact BioMedical, Inc.
Impact BioMedical, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a medical devices company | Electronic Technology |
- Stock Market
- Insiders
- Mark Suseck
















